Bydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval
Saturday, January 28, 2012 - 01:10
in Health & Medicine
The Food and Drug Administration twice declined to approve Bydureon in 2010, with its most serious concern being that the drug might contribute to heart rhythm abnormalities.